Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
SAN711
Tag: SAN711
Saniona’s CEO: “The deal with Acadia is significant”
28 November, 2024
Saniona has started dosing in the SAN711 trial
8 October, 2024
Saniona comments on the approval to initiate epilepsy study
19 September, 2024
Saniona’s CEO: “We have meetings with potential partners every week”
19 June, 2024
Saniona carves path to disrupt the epilepsy market
29 January, 2024
Saniona’s CEO shares 2024 business development roadmap
21 December, 2023
Saniona made further progress during Q3
5 December, 2023
Saniona sees potential for value-creating milestones
9 March, 2023
Saniona ready for phase I with SAN903
9 November, 2022
Saniona receives heightened interest in Q2
31 August, 2022
1
2
Page 1 of 2